Icon

EMBEDA (nda022321)- (20MG;0.8MG,30MG;1.2MG,50MG;2MG,60MG;2.4MG,80MG;3.2MG,100MG;4MG)

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE ALPHARMA PHARMS
20MG;0.8MG,30MG;1.2MG,50MG;2MG,60MG;2.4MG,80MG;3.2MG,100MG;4MG
Yes Yes
2029-Nov-07 Expired
None None
None No
EMBEDA is a combination opioid agonist/opioid antagonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
0 0 0
Total Other Developers None
Drugs with Suitability No
20MG;0.8MG ** ** - - -
30MG;1.2MG ** ** - - -
50MG;2MG ** ** - - -
60MG;2.4MG ** ** - - -
80MG;3.2MG ** ** - - -
100MG;4MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.